Navigating Eosinophilic Esophagitis Care from Recognition to Long-Term Management - Episode 14
As the EoE treatment landscape expands, new therapeutic targets may create opportunities for more individualized care. The panel closes the series by connecting emerging science with practical principles for improving long-term EoE management.
In the final episode, ‘Emerging Therapies and the Future of EoE Care,’ the panelists explored the evolving treatment landscape in eosinophilic esophagitis and reflected on key principles clinicians can apply to improve patient care. The expert faculty discussed their optimism surrounding investigational therapies with novel mechanisms of action and the potential for a broader therapeutic pipeline to provide more individualized options for patients with EoE.
The panel highlighted growing interest in targeting pathways beyond eosinophils alone, including mechanisms that may address other contributors to inflammation such as mast cells. They also discussed the importance of evaluating emerging therapies across multiple dimensions of disease, recognizing that symptoms, endoscopic findings, and histologic response may not always align. As additional treatment options become available, the panelists considered how therapies with different mechanisms could provide opportunities to better match treatment to individual disease characteristics and potentially address coexisting atopic conditions.
To close the series, the expert faculty reflected on the most important lessons from the broader discussion. They emphasized recognizing EoE as a chronic disease that requires ongoing management and building a strong clinician-patient partnership from the initial visit. Thorough assessment of symptoms, adaptive eating behaviors, comorbidities, lifestyle, and treatment preferences can help establish a foundation for individualized care and sustained engagement over time.
Ultimately, the panel emphasized treating EoE comprehensively rather than relying on a single measure of response. Integrating the patient experience with endoscopic and histologic assessment, while maintaining regular communication and shared decision-making, can help clinicians support meaningful disease control throughout the long-term treatment journey. Thank you for watching this HCPLive Peer Exchange series on eosinophilic esophagitis. Please subscribe to our eNewsletter for information on upcoming video series.